18 results for author:"Venter D.J." in Literature citations
Results Customize
› Repeat search in UniProtKB (5)
| Perturbation of the Akt/Gsk3-beta signalling pathway is common to Drosophila expressing expanded untranslated CAG, CUG and AUUCU repeat RNAs. van Eyk C.L., O'Keefe L.V., Lawlor K.T., Samaraweera S.E., McLeod C.J., Price G.R., Venter D.J., Richards R.I. Hum. Mol. Genet. 20:2783-2794(2011) · Mapped (51) |
| Sialin, an anion transporter defective in sialic acid storage diseases, shows highly variable expression in adult mouse brain, and is developmentally regulated. Yarovaya N., Schot R., Fodero L., McMahon M., Mahoney A., Williams R., Verbeek E., de Bondt A., Hampson M., van der Spek P. et al. Neurobiol. Dis. 19:351-365(2005) · Mapped (1) |
| Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers. Armes J.E., Hammet F., de Silva M., Ciciulla J., Ramus S.J., Soo W.-K., Mahoney A., Yarovaya N., Henderson M.A., Gish K. et al. Oncogene 23:5697-5702(2004) · UniProtKB (1) |
| Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA). Apicella C., Andrews L., Hodgson S.V., Fisher S.A., Lewis C.M., Solomon E., Tucker K., Friedlander M., Bankier A., Southey M.C. et al. Breast Cancer Res. 5:R206-16(2003) · Mapped (18) |
| Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer. Cui J.S., Spurdle A.B., Southey M.C., Dite G.S., Venter D.J., McCredie M.R., Giles G.G., Chenevix-Trench G., Hopper J.L. Genet. Epidemiol. 24:161-172(2003) · Mapped (3) |
| Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. Dite G.S., Jenkins M.A., Southey M.C., Hocking J.S., Giles G.G., McCredie M.R., Venter D.J., Hopper J.L. J. Natl. Cancer Inst. 95:448-457(2003) · Mapped (18) |
| Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast. Provenzano E., Hopper J.L., Giles G.G., Marr G., Venter D.J., Armes J.E. Eur. J. Cancer 39:622-630(2003) · Mapped (9) |
| The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women. Spurdle A.B., Hopper J.L., Chen X., McCredie M.R., Giles G.G., Venter D.J., Southey M.C., Chenevix-Trench G. Cancer Epidemiol. Biomarkers Prev. 11:439-443(2002) · Mapped (10) |
| The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Spurdle A.B., Hopper J.L., Chen X., Dite G.S., Cui J., McCredie M.R., Giles G.G., Ellis-Steinborner S., Venter D.J., Newman B. et al. Cancer Epidemiol. Biomarkers Prev. 11:413-416(2002) · Mapped (18) |
| Hypermethylation of the inhibin alpha-subunit gene in prostate carcinoma. Schmitt J.F., Millar D.S., Pedersen J.S., Clark S.L., Venter D.J., Frydenberg M., Molloy P.L., Risbridger G.P. Mol. Endocrinol. 16:213-220(2002) · Mapped (3) |
| The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women. Spurdle A.B., Hopper J.L., Chen X., Dite G.S., McCredie M.R., Giles G.G., Venter D.J., Southey M.C., Purdie D.M., Chenevix-Trench G. Cancer Epidemiol. Biomarkers Prev. 10:1287-1293(2001) · Mapped (1) |
| Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Lahoud M.H., Ristevski S., Venter D.J., Jermiin L.S., Bertoncello I., Zavarsek S., Hasthorpe S., Drago J., de Kretser D., Hertzog P.J. et al. |
| CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. Spurdle A.B., Hopper J.L., Dite G.S., Chen X., Cui J., McCredie M.R., Giles G.G., Southey M.C., Venter D.J., Easton D.F. et al. J. Natl. Cancer Inst. 92:1674-1681(2000) · Mapped (3) |
| Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Murphy M.A., Schnall R.G., Venter D.J., Barnett L., Bertoncello I., Thien C.B., Langdon W.Y., Bowtell D.D. Mol. Cell. Biol. 18:4872-4882(1998) · Mapped (2) |
| Chromosomal localization of the human P2y6 purinoceptor gene and phylogenetic analysis of the P2y purinoceptor family. Somers G.R., Hammet F., Woollatt E., Richards R.I., Southey M.C., Venter D.J. Genomics 44:127-130(1997) · UniProtKB (1) |
| Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice. Sumarsono S.H., Wilson T.J., Tymms M.J., Venter D.J., Corrick C.M., Kola R., Lahoud M.H., Papas T.S., Seth A., Kola I. Nature 379:534-537(1996) · Mapped (9) |
| Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Mulligan L.M., Eng C., Attie T., Lyonnet S., Marsh D.J., Hyland V.J., Robinson B.G., Frilling A., Verellen-Dumoulin C., Safar A. et al. Hum. Mol. Genet. 3:2163-2167(1994) · UniProtKB (1) |
| Molecular cloning and sequencing of the gene encoding a sheep arginine vasopressin type 1a receptor. Hutchins A.-M., Phillips P.A., Venter D.J., Burrell L.M., Johnston C.I. Biochim. Biophys. Acta 1263:266-270(1995) · UniProtKB (1) |